Social media

At Citeline’s recent panel, ICON’s Victoria DeVeaugh-Geiss explored how sponsors can embed smarter risk strategies from protocol design through execution. From AI-driven insights to cross-functional alignment, this blog ...

Early phase trials in neurodegenerative diseases demand thoughtful design, patient-centricity, and smart biomarker strategies. Join our webinar hosted by ASCPT for a focused discussion on: - Defining target populations a...

Clinical data science is redefining how we manage and interpret data in clinical trials. From integrating real-time analytics and automation to advancing risk-based quality management, the field is evolving toward smarte...

Clinical data science is redefining how we manage and interpret data in clinical trials. From integrating real-time analytics and automation to advancing risk-based quality management, the field is evolving toward smarte...

In a fast-moving market like healthcare, speed matters. Metys®, from Symphony Health, an ICON plc company, delivers weekly insights up to 3 days faster than other platforms – so you can respond to competitive shifts wi...

In a fast-moving market like healthcare, speed matters. Metys®, from Symphony Health, an ICON plc company, delivers weekly insights up to 3 days faster than other platforms – so you can respond to competitive shifts wi...

- Early planning - Stakeholder alignment - Integrated evidence generation ICON’s whitepaper outlines best practices to help you thrive under the new EU HTA regulation. Download the guide: https://ow.ly/YURE50XgHt1 #Heal...

- Early planning - Stakeholder alignment - Integrated evidence generation ICON’s whitepaper outlines best practices to help you thrive under the new EU HTA regulation. Download the guide: https://ow.ly/2wWF50XgHL8 #Heal...

Open claims datasets are a goldmine for life sciences—but they come with inevitable disruptions. Whether it’s new data sources or supplier exits, knowing how to manage change is key to maintaining strategic advantage. J...

In today’s data-rich healthcare landscape, open claims datasets offer unmatched breadth and timeliness. But disruptions—whether from new sources or supplier exits—are inevitable. Join Symphony Health, an ICON plc compan...

FDA and EMA guidance now call for endpoints that capture the full picture of patient well-being, including physical, psychological, and social. If your obesity trials aren't incorporating this multidimensional approach, ...

Identifying the differences between the clinical development processes for pediatric trials and adult trials can be difficult, especially when resources are constrained. Watch our recent webinar where Heather Peterson an...